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The molecule of the title compound, C17H10F4O, is roughly
planar, with a dihedral angle of 5.59 (14)  between the two
phenyl rings. The molecule has an E conformation with
respect to the oleﬁnic bonds. In the crystal, molecules are
connected through C—H   O hydrogen bonds and there is
slipped  –  stacking [centroid–centroid distance =
3.7983 (18), slippage =1.309 ;A ˚ ] between symmetry-related
benzene rings.
Related literature
The title compound is a derivative of the biologically active
compound curcumin [systematic name (1E,6E)-1,7-bis(4-hy-
droxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione]. For the
biological activity and applications of curcumin, see: Aggarwal
et al. (2007); Kamat et al. (2009); Liang et al. (2009); Pan et al.
(1999); Sharma et al. (2007); Zhao et al. (2010a,b). For related
structures, see: Zhao et al. (2009); Liang et al. (2007).
Experimental
Crystal data
C17H10F4O
Mr = 306.25
Monoclinic, P21=n
a = 7.7522 (11) A ˚
b = 15.413 (2) A ˚
c = 12.2848 (17) A ˚
  = 106.194 (2) 
V = 1409.6 (3) A ˚ 3
Z =4
Mo K  radiation
  = 0.13 mm
 1
T = 293 K
0.40   0.37   0.23 mm
Data collection
Bruker SMART CCD area-detector
diffractometer
Absorption correction: multi-scan
(SADABS; Bruker, 2002)
Tmin = 0.640, Tmax = 1.000
7288 measured reﬂections
2622 independent reﬂections
1612 reﬂections with I >2  (I)
Rint = 0.111
Reﬁnement
R[F
2 >2  (F
2)] = 0.063
wR(F
2) = 0.174
S = 0.94
2622 reﬂections
199 parameters
H-atom parameters constrained
 max = 0.27 e A ˚  3
 min =  0.24 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
C16—H16   O1
i 0.93 2.38 3.307 (4) 171
C8—H8   O1
ii 0.93 2.39 3.308 (3) 170
Symmetry codes: (i)  x þ 3
2;y þ 1
2; z þ 1
2; (ii)  x þ 1
2;y   1
2; z þ 1
2.
Data collection: SMART (Bruker, 2002); cell reﬁnement: SAINT
(Bruker, 2002); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009); software
used to prepare material for publication: SHELXTL.
The use of the X-ray crystallographic service at the
Shanghai Institute of Organic Chemistry, Chinese Academy of
Sciences, and the valuable assistance of the staff there is
gratefully acknowledged.
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: DN2659).
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(1E,4E)-1,5-Bis(2,6-difluorophenyl)penta-1,4-dien-3-one
J.-D. Huang, Q.-Q. Tang, X.-Y. Chen, Y. Ye and Y. Wang
Comment
The title compound, (1E,4E)-1,5-bis (2,6-difluorophenyl) penta-1,4-dien-3-one (I), is one of mono-carbonyl analogues of
curcumin designed and synthesized by our group.Curcumin (diferuloylmethane ) is the main component of turmeric, the
powdered root of Curcuma longa Linn. Traditionally, curcumin has been used as a medicine for liver disease, indigestion,
urinary tract diseases, rheumatoid arthritis, and insect bites (Aggarwal et al., 2007; Kamat et al., 2009). The pharmacological
safety of curcumin has been demonstrated by its consumption for centuries at levels of up to 100 mg/day by people in
certain countries (Pan et al., 1999). One potential problem with the clinical use of curcumin is its low bioavailability and
poor absorption characteristics ( Sharma et al., 2007); however, curcumin remains an ideal leading compound for design
of some effective analogues. In our previous study, a series of fluorine-containing, mono-carbonyl analogues of curcumin
were designed and synthesized by the deletion of β-diketone moiety, and their bioactivities were evaluated (Liang et al.,
2009; Zhao et al., 2010a,b). Among those compounds, some analogues exhibited better anti-tumor properties and a wider
anti-tumor spectrum than curcumin. As a continuation of our broad program of work on the synthesis and structural study
of curcumin analogues, the title curcumin derivative has been obtained and an X-ray diffraction study was carried out.
Therefore, the structure of one of compounds (I), was further determined and analyzed using single-crystal X-ray diffraction.
Accumulation of detailed structural and pharmacological data facilitated the explanation of the observed structure–activity
relationships and modeling of new compounds with potential biological activity.
The molecule (I), consists of two 2,6-difluoophenyl rings linked through a penta-1,4-dien-3-one chain (Fig. 1). The mo-
lecule displays an E conformation with respect to the olefinic bonds, exhibiting a butterfly-shaped geometry. The whole
molecule is roughly planar with a dihedral angle between the two terminal phenyl rings of 5.59 (14)°. Among these deriv-
atives, the structures of some of them were reported ( Liang et al., 2007; Zhao et al., 2009; Zhao et al., 2010a,b).
In the crystal, the molecule are connected through C-H···O hydrogen bonds and slippest π-π stacking between symmetry
related phenyl rings (Tables 1 and 2, Fig. 2).
Experimental
Acetone (7.5 mmol) was dissolved in ethanol (5 ml) and crushed KOH (15 mmol) was added. The flask was immersed in
a bath of crushed ice and a solution of 2,6-difluorobenzaldehyde (15 mmol) in ethanol (5 mmol) was added. The reaction
mixture was stirred at 300 K and completion of the reaction was monitored by thin-layer chromatography. Ice-cold water
was added to the reaction mixture after 48 h and the yellow solid that separated was filtered off, washed with water and cold
ethanol, dried and purified by column chromatography on silica gel (yield: 49.3%). Single crystals of the title compound
were grown in a CH2Cl2/CH3OH mixture (5:2 v/v) by slow evaporation .supplementary materials
sup-2
Yellow powder, 49.3% yield, mp 135-138°C. 1H-NMR (CDCl3) δ: 6.95 (4H, t, Ar-H3,5×2), 7.29 (2H, d, J=18.0Hz, =CH-
C=O×2), 7.31-7.36 (2H, m, Ar-H4×2), 7.81 (2H, d, J=18.0Hz, Ar-CH=C×2). ESI-MS m/z: 307.7 (M+1)+ 329.6 (M+Na)
635.3 (2M+Na), calcd for C17H10F4O: 306.25.
Refinement
The H atoms were positioned geometrically (C—H = 0.93 and 0.96 Å) and refined as riding with Uiso(H) = 1.2Ueq(C) or
1.5Ueq(methyl C).
Figures
Fig. 1. The molecular structure of the title compound with the atom labeling scheme. Dis-
placement ellipsoids are drawn at the 30% probability level. Hydrogen atoms are represented
as small spheres of arbitrary radii.
Fig. 2. Partial packing view showing the C-H···O hydrogen bonds and the π-π stacking. H
atoms not involved in hydrogen bondings have been omitted for clarity. Hydrogen bonds are
shown as dashed lines. [Symmetry codes: (i) -x+3/2, y+1/2, -z+1/2; (ii) -x+1/2, y-1/2, -z+1/2]
(1E,4E)-1,5-Bis(2,6-difluorophenyl)penta-1,4-dien-3-on
Crystal data
C17H10F4O F(000) = 624
Mr = 306.25 Dx = 1.443 Mg m−3
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2yn Cell parameters from 1937 reflections
a = 7.7522 (11) Å θ = 5.3–44.2°
b = 15.413 (2) Å µ = 0.13 mm−1
c = 12.2848 (17) Å T = 293 K
β = 106.194 (2)° Prismatic, green
V = 1409.6 (3) Å3 0.40 × 0.37 × 0.23 mm
Z = 4
Data collection
Bruker SMART CCD area-detector
diffractometer
2622 independent reflections
Radiation source: fine-focus sealed tube 1612 reflections with I > 2σ(I)
graphite Rint = 0.111
φ and ω scans θmax = 25.5°, θmin = 2.2°
Absorption correction: multi-scan
(SADABS; Bruker, 2002)
h = −9→8supplementary materials
sup-3
Tmin = 0.640, Tmax = 1.000 k = −10→18
7288 measured reflections l = −13→14
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.063
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.174 H-atom parameters constrained
S = 0.94
w = 1/[σ2(Fo
2) + (0.0971P)2]
where P = (Fo
2 + 2Fc
2)/3
2622 reflections (Δ/σ)max < 0.001
199 parameters Δρmax = 0.27 e Å−3
0 restraints Δρmin = −0.24 e Å−3
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculat-
ing R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice
as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
F1 0.1321 (2) −0.05696 (10) −0.13761 (11) 0.0953 (6)
F2 0.2040 (3) −0.14772 (13) 0.23505 (14) 0.1253 (7)
F3 0.4725 (3) 0.31282 (12) −0.12340 (13) 0.1193 (7)
F4 0.7788 (3) 0.37861 (11) 0.25107 (15) 0.1277 (7)
O1 0.4636 (3) 0.11929 (12) 0.21918 (15) 0.0902 (6)
C1 0.4216 (3) 0.12103 (15) 0.1155 (2) 0.0650 (6)
C2 0.3222 (3) 0.04845 (15) 0.0490 (2) 0.0651 (6)
H2 0.2925 0.0506 −0.0297 0.078*
C3 0.2739 (3) −0.01982 (16) 0.09889 (19) 0.0665 (6)
H3 0.3101 −0.0180 0.1777 0.080*
C4 0.1752 (3) −0.09625 (15) 0.05189 (18) 0.0625 (6)
C5 0.1051 (3) −0.11493 (15) −0.06245 (19) 0.0654 (6)
C6 0.0106 (3) −0.18811 (17) −0.1029 (2) 0.0761 (7)
H6 −0.0336 −0.1970 −0.1806 0.091*
C7 −0.0187 (4) −0.24790 (18) −0.0290 (3) 0.0816 (8)
H7 −0.0837 −0.2979 −0.0561 0.098*supplementary materials
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C8 0.0473 (4) −0.23481 (19) 0.0854 (3) 0.0908 (8)
H8 0.0285 −0.2755 0.1368 0.109*
C9 0.1404 (4) −0.16122 (19) 0.1214 (2) 0.0793 (7)
C10 0.4659 (3) 0.19589 (16) 0.0545 (2) 0.0672 (6)
H10 0.4252 0.1973 −0.0242 0.081*
C11 0.5625 (3) 0.26144 (16) 0.10904 (19) 0.0657 (6)
H11 0.5979 0.2561 0.1876 0.079*
C12 0.6217 (3) 0.33956 (16) 0.06650 (19) 0.0652 (6)
C13 0.5821 (3) 0.36416 (17) −0.0465 (2) 0.0776 (7)
C14 0.6445 (4) 0.4382 (2) −0.0837 (3) 0.0964 (9)
H14 0.6124 0.4518 −0.1605 0.116*
C15 0.7535 (4) 0.4915 (2) −0.0071 (3) 0.0980 (9)
H15 0.7977 0.5417 −0.0316 0.118*
C16 0.7993 (4) 0.4721 (2) 0.1059 (3) 0.1009 (9)
H16 0.8741 0.5086 0.1588 0.121*
C17 0.7330 (3) 0.39840 (19) 0.1388 (2) 0.0832 (7)
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
F1 0.1352 (13) 0.0939 (11) 0.0506 (8) −0.0214 (9) 0.0155 (8) 0.0034 (7)
F2 0.1765 (17) 0.1274 (15) 0.0600 (10) −0.0324 (12) 0.0129 (10) 0.0212 (9)
F3 0.1636 (15) 0.1215 (14) 0.0553 (9) −0.0532 (12) 0.0018 (10) 0.0006 (9)
F4 0.1733 (17) 0.1124 (14) 0.0678 (11) −0.0292 (12) −0.0153 (10) −0.0118 (10)
O1 0.1242 (15) 0.0820 (13) 0.0543 (11) −0.0036 (10) 0.0084 (10) −0.0012 (8)
C1 0.0676 (14) 0.0680 (15) 0.0553 (14) 0.0125 (11) 0.0102 (11) −0.0008 (11)
C2 0.0719 (14) 0.0696 (15) 0.0512 (13) 0.0085 (11) 0.0131 (11) −0.0007 (11)
C3 0.0693 (14) 0.0775 (17) 0.0506 (13) 0.0115 (12) 0.0134 (11) 0.0023 (12)
C4 0.0636 (13) 0.0656 (14) 0.0564 (14) 0.0099 (11) 0.0138 (10) 0.0024 (11)
C5 0.0739 (14) 0.0653 (15) 0.0564 (14) 0.0119 (12) 0.0175 (11) 0.0070 (11)
C6 0.0829 (16) 0.0755 (17) 0.0668 (16) 0.0058 (14) 0.0154 (13) −0.0075 (13)
C7 0.0841 (17) 0.0689 (17) 0.093 (2) 0.0029 (13) 0.0272 (16) −0.0040 (15)
C8 0.107 (2) 0.0768 (19) 0.093 (2) 0.0019 (16) 0.0336 (18) 0.0170 (16)
C9 0.0933 (18) 0.0828 (19) 0.0561 (15) 0.0050 (15) 0.0114 (13) 0.0086 (13)
C10 0.0671 (14) 0.0771 (17) 0.0525 (13) 0.0059 (12) 0.0088 (11) −0.0050 (12)
C11 0.0675 (13) 0.0731 (16) 0.0518 (13) 0.0063 (12) 0.0087 (11) −0.0052 (11)
C12 0.0629 (13) 0.0707 (16) 0.0588 (14) 0.0052 (11) 0.0118 (11) −0.0061 (11)
C13 0.0811 (16) 0.0853 (18) 0.0611 (15) −0.0131 (14) 0.0109 (12) −0.0040 (13)
C14 0.111 (2) 0.096 (2) 0.0788 (19) −0.0156 (18) 0.0214 (17) 0.0115 (16)
C15 0.099 (2) 0.082 (2) 0.112 (3) −0.0120 (16) 0.0258 (19) 0.0076 (18)
C16 0.094 (2) 0.081 (2) 0.112 (3) −0.0177 (17) 0.0032 (18) −0.0135 (18)
C17 0.0870 (17) 0.0844 (19) 0.0655 (17) −0.0005 (15) 0.0004 (13) −0.0089 (14)
Geometric parameters (Å, °)
F1—C5 1.342 (3) C7—H7 0.9300
F2—C9 1.361 (3) C8—C9 1.351 (4)
F3—C13 1.339 (3) C8—H8 0.9300
F4—C17 1.360 (3) C10—C11 1.323 (3)supplementary materials
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O1—C1 1.224 (3) C10—H10 0.9300
C1—C10 1.468 (3) C11—C12 1.438 (3)
C1—C2 1.470 (3) C11—H11 0.9300
C2—C3 1.323 (3) C12—C13 1.388 (3)
C2—H2 0.9300 C12—C17 1.389 (3)
C3—C4 1.436 (3) C13—C14 1.367 (4)
C3—H3 0.9300 C14—C15 1.353 (4)
C4—C5 1.388 (3) C14—H14 0.9300
C4—C9 1.390 (4) C15—C16 1.367 (4)
C5—C6 1.361 (3) C15—H15 0.9300
C6—C7 1.357 (4) C16—C17 1.354 (4)
C6—H6 0.9300 C16—H16 0.9300
C7—C8 1.370 (4)
O1—C1—C10 121.1 (2) F2—C9—C4 116.3 (2)
O1—C1—C2 120.5 (2) C11—C10—C1 121.5 (2)
C10—C1—C2 118.4 (2) C11—C10—H10 119.3
C3—C2—C1 121.3 (2) C1—C10—H10 119.3
C3—C2—H2 119.3 C10—C11—C12 130.4 (2)
C1—C2—H2 119.3 C10—C11—H11 114.8
C2—C3—C4 130.9 (2) C12—C11—H11 114.8
C2—C3—H3 114.6 C13—C12—C17 112.7 (2)
C4—C3—H3 114.6 C13—C12—C11 126.0 (2)
C5—C4—C9 112.6 (2) C17—C12—C11 121.2 (2)
C5—C4—C3 126.3 (2) F3—C13—C14 118.1 (2)
C9—C4—C3 121.1 (2) F3—C13—C12 117.6 (2)
F1—C5—C6 118.1 (2) C14—C13—C12 124.2 (3)
F1—C5—C4 117.8 (2) C15—C14—C13 119.0 (3)
C6—C5—C4 124.1 (2) C15—C14—H14 120.5
C7—C6—C5 119.4 (3) C13—C14—H14 120.5
C7—C6—H6 120.3 C14—C15—C16 120.6 (3)
C5—C6—H6 120.3 C14—C15—H15 119.7
C6—C7—C8 120.2 (3) C16—C15—H15 119.7
C6—C7—H7 119.9 C17—C16—C15 118.3 (3)
C8—C7—H7 119.9 C17—C16—H16 120.9
C9—C8—C7 118.2 (3) C15—C16—H16 120.9
C9—C8—H8 120.9 C16—C17—F4 118.5 (3)
C7—C8—H8 120.9 C16—C17—C12 125.2 (3)
C8—C9—F2 118.1 (2) F4—C17—C12 116.2 (3)
C8—C9—C4 125.5 (3)
O1—C1—C2—C3 0.7 (3) O1—C1—C10—C11 4.4 (3)
C10—C1—C2—C3 −178.2 (2) C2—C1—C10—C11 −176.71 (19)
C1—C2—C3—C4 178.8 (2) C1—C10—C11—C12 179.4 (2)
C2—C3—C4—C5 −0.4 (4) C10—C11—C12—C13 2.2 (4)
C2—C3—C4—C9 179.5 (2) C10—C11—C12—C17 −175.9 (2)
C9—C4—C5—F1 −179.4 (2) C17—C12—C13—F3 −178.6 (2)
C3—C4—C5—F1 0.5 (3) C11—C12—C13—F3 3.1 (4)
C9—C4—C5—C6 0.8 (3) C17—C12—C13—C14 −0.2 (4)
C3—C4—C5—C6 −179.3 (2) C11—C12—C13—C14 −178.5 (2)supplementary materials
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F1—C5—C6—C7 179.9 (2) F3—C13—C14—C15 179.2 (3)
C4—C5—C6—C7 −0.2 (4) C12—C13—C14—C15 0.8 (5)
C5—C6—C7—C8 −0.3 (4) C13—C14—C15—C16 −0.7 (5)
C6—C7—C8—C9 0.3 (4) C14—C15—C16—C17 0.1 (5)
C7—C8—C9—F2 179.2 (2) C15—C16—C17—F4 179.7 (3)
C7—C8—C9—C4 0.4 (4) C15—C16—C17—C12 0.5 (5)
C5—C4—C9—C8 −0.9 (4) C13—C12—C17—C16 −0.4 (4)
C3—C4—C9—C8 179.2 (2) C11—C12—C17—C16 177.9 (3)
C5—C4—C9—F2 −179.7 (2) C13—C12—C17—F4 −179.6 (2)
C3—C4—C9—F2 0.4 (3) C11—C12—C17—F4 −1.3 (4)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
C16—H16···O1i 0.93 2.38 3.307 (4) 171
C8—H8···O1ii 0.93 2.39 3.308 (3) 170
Symmetry codes: (i) −x+3/2, y+1/2, −z+1/2; (ii) −x+1/2, y−1/2, −z+1/2.
Table 2
Table 2 π-π stacking interactions (Å)
Cg1 is the centroid of the C12-C17 ring.
CgI CgJ CgI···CgJa CgI···P(J)b CgJ···P(I)c Slippage
Cg1 Cg1iii 3.7983 (18) 3.5656 (12) 3.5656 (12) 1.309
Symmetry codes: (iii)1-x,1-y,-z Notes: a : Distance between centroids b : Perpendicular distance of CgI on ring plan J. c : Perpendicu-
lar distance of CgJ on ring plan I. Slippage = vertical displacement between ring centroids.supplementary materials
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Fig. 1supplementary materials
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Fig. 2